A publication in Nature in April 2026 reports that N-desethyl-fluornitrazene (DFNZ), a modified nitazene and µ-opioid receptor (MOR) superagonist, produced potent analgesia in rodents with less respi… [+4610 chars]
Read Full Story
How the opioid superagonist DFNZ challenges pain medicine
Posted on April 5, 2026 at 